These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 10456614

  • 21. The effect of ciprofibrate on flow-mediated dilation and inflammatory markers in patients with combined hyperlipidemia.
    Kovács I, Toldy E, Abel T, Tarján J, Császár A.
    Endothelium; 2005; 12(4):179-83. PubMed ID: 16162440
    [Abstract] [Full Text] [Related]

  • 22. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J, Bird RP.
    Cancer Res; 2003 Oct 15; 63(20):6595-601. PubMed ID: 14583451
    [Abstract] [Full Text] [Related]

  • 23. C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells.
    Igaz P, Bösze S, Tóth S, Falus A, Hudecz F.
    Biol Chem; 2001 Apr 15; 382(4):669-76. PubMed ID: 11405230
    [Abstract] [Full Text] [Related]

  • 24. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
    Lu HQ, Zheng J.
    Ai Zheng; 2006 Dec 15; 25(12):1470-6. PubMed ID: 17166369
    [Abstract] [Full Text] [Related]

  • 25. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
    Bermúdez-Pirela V, Souki A, Cano-Ponce C, Bermúdez-Arias F, Mengual-Moreno E, Leal-Gonzalez E, Lemus-Antepaz M, de Bravo MC, de Díaz AA, de Pirela NL, Cano-Peñaloza R, Puche-Medina G, Arraiz N, Reyna-Villazmil N, Contreras F, Israili ZH, Valasco M.
    Am J Ther; 2007 Dec 15; 14(2):213-20. PubMed ID: 17414592
    [Abstract] [Full Text] [Related]

  • 26. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
    Kim MS, Wang S, Shen Z, Kochansky CJ, Strauss JR, Franklin RB, Vincent SH.
    Drug Metab Dispos; 2004 Sep 15; 32(9):909-14. PubMed ID: 15319330
    [Abstract] [Full Text] [Related]

  • 27. Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha.
    Huang TH, Peng G, Li GQ, Yamahara J, Roufogalis BD, Li Y.
    Toxicol Appl Pharmacol; 2006 Feb 01; 210(3):225-35. PubMed ID: 15975614
    [Abstract] [Full Text] [Related]

  • 28. Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet.
    Cicero AF, Vitale G, Savino G, Arletti R.
    Phytother Res; 2003 Feb 01; 17(2):174-8. PubMed ID: 12601683
    [Abstract] [Full Text] [Related]

  • 29. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C, Samson P, Lalonde J, Richard D.
    J Endocrinol; 2007 Apr 01; 193(1):11-9. PubMed ID: 17400798
    [Abstract] [Full Text] [Related]

  • 30. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB.
    Cancer Res; 2002 Jul 15; 62(14):3997-4006. PubMed ID: 12124333
    [Abstract] [Full Text] [Related]

  • 31. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA, Rodríguez-Roa E, Nagy E, Mijares ME, Rodríguez-Larralde A, Gil A, Lundberg U, Carvajal Z, Castillo L, Arocha-Piñango CL.
    Invest Clin; 2006 Mar 15; 47(1):35-48. PubMed ID: 16562643
    [Abstract] [Full Text] [Related]

  • 32. The effect of deferoxamine on ciprofibrate-induced hepatocarcinogenesis in the rat.
    Rao MS, Subbarao V.
    In Vivo; 1997 Mar 15; 11(6):495-8. PubMed ID: 9509299
    [Abstract] [Full Text] [Related]

  • 33. Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-alpha.
    Martinsen TC, Bakke I, Chen D, Sandvik AK, Zahlsen K, Aamo T, Waldum HL.
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec 15; 289(6):G1052-60. PubMed ID: 16099866
    [Abstract] [Full Text] [Related]

  • 34. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK, Chae YN, Son MH, Kim SH, Kim JK, Moon HS, Park CS, Bae MH, Kim E, Han T, Choi HH, Shin YA, Ahn BN, Lee CH, Lim JI, Shin CY.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):119-25. PubMed ID: 18727927
    [Abstract] [Full Text] [Related]

  • 35. Lateral hypothalamic serotonergic responsiveness to food intake in rat obesity as measured by microdialysis.
    Mori RC, Guimarães RB, Nascimento CM, Ribeiro EB.
    Can J Physiol Pharmacol; 1999 Apr 24; 77(4):286-92. PubMed ID: 10535677
    [Abstract] [Full Text] [Related]

  • 36. The metabolic and microcirculatory impact of orthotopic liver transplantation on the obese Zucker rat.
    Sun CK, Zhang XY, Zimmermann A, Wheatley AM.
    Transplantation; 2003 Mar 27; 75(6):761-9. PubMed ID: 12660498
    [Abstract] [Full Text] [Related]

  • 37. The detection of phenotypic differences in the metabolic plasma profile of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry.
    Plumb RS, Johnson KA, Rainville P, Shockcor JP, Williams R, Granger JH, Wilson ID.
    Rapid Commun Mass Spectrom; 2006 Mar 27; 20(19):2800-6. PubMed ID: 16941721
    [Abstract] [Full Text] [Related]

  • 38. The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E.
    Fu T, Kashireddy P, Borensztajn J.
    Biochem J; 2003 Aug 01; 373(Pt 3):941-7. PubMed ID: 12713444
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia].
    Gajdos M, Fedelesova V, Mongiellova V, Cibulova L, Huttova D, Polak F, Krivosikova Z.
    Bratisl Lek Listy; 1999 Aug 01; 100(8):449-53. PubMed ID: 10645034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.